Lido Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1650150 Los Angeles, CA

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$19,429,401

-$4,869,334 QoQ

Shares Held

43,511

-18.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 54.606881018593.ToString("F0")% Shared 0.ToString("F0")% None 45.393118981407.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$133,962

PutShares

300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Lido Advisors, LLC holds $41,372,144 across 33 Biotechnology names. VRTX ranks #1 (47.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	43,511	$19,429,401
2	REGN	Regeneron Pharmaceuticals, Inc.	11,739	$9,070,020
3	IDYA	IDEAYA Biosciences, Inc.	55,463	$1,848,027
4	TARS	Tarsus Pharmaceuticals, Inc.	24,374	$1,709,836
5	INCY	Incyte Corp	13,037	$1,227,042
6	IMNM	Immunome Inc.	48,950	$1,070,536
7	RPRX	Royalty Pharma plc	19,254	$923,614
8	CPRX	Catalyst Pharmaceuticals, Inc.	26,841	$664,583

All Filings in VRTX

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$133,962	300	-99.3%	Put	Sole	2026-05-13
2026-03-31	$19,429,401	43,511	+14403.7%	Shares	Defined	2026-05-13
2025-12-31	$136,008	300	-99.4%	Put	Sole	2026-02-10
2025-12-31	$24,298,735	53,597	+17765.7%	Shares	Defined	2026-02-10
2025-09-30	$117,492	300	-99.4%	Put	Sole	2025-11-14
2025-09-30	$21,029,108	53,695	+17.2%	Shares	Sole	2025-11-14
2025-06-30	$20,399,952	45,822	+15174.0%	Shares	Defined	2025-08-13
2025-06-30	$133,560	300	-99.1%	Put	Sole	2025-08-13
2025-03-31	$16,596,356	34,232	+2533.2%	Shares	Defined	2025-05-15
2025-03-31	$630,266	1,300	-95.9%	Put	Sole	2025-05-15
2024-12-31	$12,727,734	31,606	+2331.2%	Shares	Defined	2025-02-14
2024-12-31	$523,510	1,300	-94.7%	Put	Sole	2025-02-14
2024-09-30	$11,347,486	24,399	+1776.8%	Shares	Sole	2024-11-14
2024-09-30	$604,604	1,300	0.0%	Put	Sole	2024-11-14
2024-06-30	$609,336	1,300	-94.6%	Put	Sole	2024-08-15
2024-06-30	$11,279,276	24,064	+2.3%	Shares	Defined	2024-08-15
2024-03-31	$9,837,446	23,534	+1468.9%	Shares	Defined	2024-05-15
2024-03-31	$627,015	1,500	-93.7%	Put	Sole	2024-05-15
2023-12-31	$9,611,961	23,623	+1474.9%	Shares	Defined	2024-02-14
2023-12-31	$610,335	1,500	-96.1%	Put	Sole	2024-02-14
2023-09-30	$13,545,515	38,953	+2496.9%	Shares	Sole	2023-11-14
2023-09-30	$521,610	1,500	-91.3%	Put	Sole	2023-11-14
2023-06-30	$6,050,034	17,192	-29.2%	Shares	Sole	2023-08-09
2023-03-31	$7,649,583	24,279	-14.0%	Shares	Defined	2023-05-15
2022-12-31	$8,152,836	28,232	+76.5%	Shares	Sole	2023-02-14
2022-09-30	$4,632,060	15,998	+285.8%	Shares	Defined	2022-11-14
2022-06-30	$1,168,583	4,147	+2.3%	Shares	Sole	2022-08-15
2022-03-31	$1,058,233	4,055	+21.3%	Shares	Sole	2022-05-17
2021-12-31	$734,122	3,343	+43.5%	Shares	Sole	2022-02-15
2021-09-30	$422,638	2,330	+14.5%	Shares	Sole	2022-02-15
2021-06-30	$410,317	2,035	+11.9%	Shares	Sole	2021-08-12
2021-03-31	$390,884	1,819	-6.7%	Shares	Sole	2021-05-13
2020-12-31	$460,626	1,949	+7.1%	Shares	Sole	2021-02-08
2020-09-30	$494,986	1,819	+13.1%	Shares	Sole	2020-11-12
2020-06-30	$466,818	1,608	+8.6%	Shares	Sole	2020-08-12
2020-03-31	$352,166	1,480	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.